GlucoTrack, Inc.
GCTK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,927 | $2,967 | $3,894 | $147,785 |
| - Cash | $7,869 | $9,555 | $9,100 | $5,617 |
| + Debt | $40 | $267 | $262 | $267 |
| Enterprise Value | -$1,902 | -$6,321 | -$4,944 | $142,435 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$9 | -$11 | -$8 | -$14 |
| % Margin | – | – | – | – |
| EBITDA | -$4,162 | -$4,745 | -$6,825 | -$10,080 |
| % Margin | – | – | – | – |
| Net Income | -$4,171 | -$4,756 | -$6,833 | -$10,094 |
| % Margin | – | – | – | – |
| EPS Diluted | 4.64 | -9.62 | -0.67 | -21.75 |
| % Growth | 148.2% | -1,335.8% | 96.9% | – |
| Operating Cash Flow | – | -$3,744 | -$2,939 | -$3,499 |
| Capital Expenditures | – | $0 | -$9 | $0 |
| Free Cash Flow | – | -$3,744 | -$2,948 | -$3,499 |